Back to search
FDAFDA · Food and drugs·Recall number D-0603-2017

Buffered Lidocaine, 1%, In Sodium Bicarbonate 8.4%, 1 mL Total Volume in a 3 mL syringe, Local anesthetic use, Rx only, PharMEDium, Product code 2K2466

Published March 22, 2017 · Recall initiated: January 27, 2017

Summary

FDA records drug Class III recall D-0603-2017, published March 22, 2017 and initiated January 27, 2017. Recalling firm: Pharmedium Services, LLC; Status: Terminated; Reported quantity: 3879 syringes; Lot: Lot Numbers: 170110030M, 170110029M and 170070058M. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling; Label Mixup; outer packaging is incorrectly labeled as Buffered Lidocaine 1% instead of correctly as Buffered Lidocaine 0.9%

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmedium Services, LLC
Distributor
Nationwide
Lot
Lot Numbers: 170110030M, 170110029M and 170070058M
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Buffered Lidocaine, 1%, In Sodium Bicarbonate 8.4%, 1 mL Total Volume in a 3 mL syringe, Local anesthetic use, Rx only, PharMEDium, Product code 2K2466 recalled?

Yes. FDA published recall D-0603-2017 on March 22, 2017. Reported hazard: Labeling; Label Mixup; outer packaging is incorrectly labeled as Buffered Lidocaine 1% instead of correctly as Buffered Lidocaine 0.9%

What should I do if I have this product?

Voluntary: Firm initiated · Telephone